Vericel Corp - Company Profile
Powered by
All the data and insights you need on Vericel Corp in one report.
- Save hours of research time and resources with
our up-to-date Vericel Corp Strategy Report
- Understand Vericel Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Vericel Corp (Vericel) develops and markets advanced cell therapies for sports medicine and severe burn care domain. Its major products include MACI (autologous cultured chondrocytes on porcine collagen membrane) for the treatment of cartilage defects; and Epicel cultured epidermal autografts for skin replacement. It also holds an exclusive license for NexoBrid in North America for the treatment of severe thermal burns. The company has manufacturing facility in Cambridge, Massachusetts and sells its products to sports medicine orthopedic surgeons and specialized burn centers through cell therapy specialists in the US. Vericel is headquartered in Cambridge, Massachusetts, the US.
Vericel Corp premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Cultured Epidermal Autograft | MACI |
Autologous Cultured Chondrocytes on Porcine Collagen Membrane – MACI | NexoBrid |
Preapproval Product: | Epicel |
XYZ | |
XYZ | |
XYZ |
Competitor Comparison
Key Parameters | Vericel Corp | Stryker Corp | Zimmer Biomet Holdings Inc | Anika Therapeutics Inc | Aesculap Biologics LLC |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | Cambridge | Kalamazoo | Warsaw | Bedford | Breinigsville |
State/Province | Massachusetts | Michigan | Indiana | Massachusetts | Pennsylvania |
No. of Employees | 314 | 52,000 | 18,000 | 345 | - |
Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Robert L. Zerbe, M.D. | Chairman | Executive Board | 2012 | 71 |
Dominick C. Colangelo | Director; Chief Executive Officer; President | Executive Board | 2013 | 58 |
Joe Mara | Chief Financial Officer | Senior Management | 2021 | 47 |
Michael Halpin | Chief Operating Officer | Senior Management | 2017 | 60 |
Jonathan Hopper | Chief Medical Officer | Senior Management | 2018 | 59 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer